Laboratory testing firm Eurofins Scientific saw its shares climb to a two-month peak after confirming the divestiture of its electrical and electronics testing arm, MET Labs. The transaction immediately boosted investor sentiment toward the Luxembourg-based company, signaling a strategic pivot toward streamlining operations and managing its balance sheet.

U.S. safety group UL Solutions agreed to purchase the division for 575 million euros ($676.2 million). MET Labs specializes in electrical safety checks and product certification for the American market. Eurofins intends to deploy the massive cash infusion to systematically reduce its existing debt obligations.

Further proceeds from the sale are earmarked for reinvestment directly into Eurofins' core laboratory infrastructure and executing targeted share buyback programs. Management projects MET Labs would have generated revenues exceeding 180 million euros by 2026, making this a substantial exit.

Selling this specialized unit allows Eurofins to sharpen its focus on other testing segments while deleveraging its structure. The market reacted positively to the clear use of funds, reinforcing confidence in management's capital allocation strategy.